Correlation analysis showed a strong positive correlation between the chondroblastic and hypertrophic zones only in the untreated CFA group (r = 0.934, p < 0.001).
A two-session 810-nm diode laser PBM protocol reduced pain on day 1 after initial fixed orthodontic appliance placement and was associated with higher patient-reported satisfaction in dietary, psychological, and speech-related domains during the first week.
The P2/P1 ratio did not change significantly. Without a sham-treated group, these findings indicate preliminary associations rather than treatment efficacy or causality.
Although some comparative studies reported greater pain reduction with LLLT/PBM than with ultrasound, this finding should be interpreted cautiously because the number of studies was small and treatment protocols were heterogeneous.
This meta-analysis suggests that laser therapy may reduce acute incisional pain and analgesic requirements during the first 48 h after CS. However, substantial heterogeneity and limited evidence preclude conclusive recommendations.
Pain decreased and functional independence improved during the postoperative period. However, the combination of TENS and low-level laser photobiomodulation did not provide additional benefits compared with the other groups.
Trial · October 22, 2026 · de Holanda Araújo Sena AMP et al.
Given the small and heterogeneous evidence base and its methodological limitations, current evidence remains insufficient to establish superiority over conventional osseous crown-lengthening surgery or to identify an optimal laser protocol.
Clinical outcomes improved over time without evidence of differential changes between interventions. Thermography identified region-specific ΔT trajectories, warranting further investigation as a complementary method.
Photobiomodulation demonstrates pain reduction superior to sham controls in several myogenous TMD trials. However, due to low GRADE certainty and evidence inconsistency, it should be considered a complementary treatment option rather than a standalone therapy.
Extraoral PBM demonstrated comparable effectiveness to intraoral for OM prevention in pediatric patients undergoing HDMTX chemotherapy, while reducing application time.
Adding PBMT to MCE did not provide clinically important additional improvements in pain intensity, disability or circulating PGE2 concentrations compared with sham plus the same exercise program.
Repeated 850-nm LED PBM was associated with reduced cumulative pain and attenuated DSP increases during canine distalization, suggesting potential benefits for patient comfort and root resorption-related responses.
Transcription of POLβ gene was not significantly affected. These findings suggest that PBM modulates the relative mRNA levels of genes involved in both the short-patch and long-patch BER pathways in zymosan-induced arthritis.